AberrantKeap1methylation in breast cancer and association with clinicopathological features
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AberrantKeap1methylation in breast cancer and association with clinicopathological features
Authors
Keywords
-
Journal
Epigenetics
Volume 8, Issue 1, Pages 105-112
Publisher
Informa UK Limited
Online
2012-12-19
DOI
10.4161/epi.23319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methylation of the KEAP1 gene promoter region in human colorectal cancer
- (2012) Naoyuki Hanada et al. BMC CANCER
- Keap1: One stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL
- (2012) Hui Tian et al. CANCER LETTERS
- Somatic mutations of the KEAP1 gene in common solid cancers
- (2012) Nam Jin Yoo et al. HISTOPATHOLOGY
- Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
- (2011) Peeter Karihtala et al. BMC CANCER
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- Regulation ofKEAP1expression by promoter methylation in malignant gliomas and association with patient’s outcome
- (2011) Lucia Anna Muscarella et al. Epigenetics
- Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
- (2011) Lucia Anna Muscarella et al. Epigenetics
- Association of Keap1 and Nrf2 Genetic Mutations and Polymorphisms With Endometrioid Endometrial Adenocarcinoma Survival
- (2011) Tze Fang Wong et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Inhibitor of Nrf2 (INrf2 or Keap1) Protein Degrades Bcl-xL via Phosphoglycerate Mutase 5 and Controls Cellular Apoptosis
- (2011) Suryakant K. Niture et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer
- (2010) Yuan Yao et al. BREAST CANCER RESEARCH AND TREATMENT
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis
- (2010) S K Niture et al. CELL DEATH AND DIFFERENTIATION
- Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features
- (2010) L. M. Solis et al. CLINICAL CANCER RESEARCH
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters
- (2009) Guoxiang Shen et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1–NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds
- (2009) A.Kenneth MacLeod et al. CARCINOGENESIS
- KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
- (2009) Dung-Fang Lee et al. MOLECULAR CELL
- NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
- (2009) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
- (2008) Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
- (2008) T. Ohta et al. CANCER RESEARCH
- Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
- (2008) Tatsuhiro Shibata et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More